Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
10 participants
OBSERVATIONAL
2017-04-07
2018-03-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
METHODS: This is a cross-sectional study involving 10 healthy male volunteers. The development of the method will take place in 3 stages. The first step corresponds to the characterization of the inspiratory and expiratory curves in the respiratory cycle generated by the impedance variation (ΔZ), the mobility of the chest wall and the pulmonary volume curve during maximal respiratory maneuvers. 2nd stage: verification of the correlation between the variables Step 3: Estimate the dislocated blood volume of the lung through previous analyzes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Electrical Impedance Tomography in Evaluating the Effects of Noninvasive Ventilation in Post-Operative Cardiac Surgery
NCT03371628
Ventilatory Monitoring in Children With Respiratory Distress Syndrome With Electrical Impedance Tomography
NCT03768921
Lungs Aeration Changes Examined by Impedance Tomography During High Frequency Jet Ventilation.
NCT02997072
Regional Lung Opening and Closing Pressures in Patients With Acute Lung Injury
NCT01107847
Imbalances of Regional Pulmonary Ventilation in Patients With Post-acute-COVID-19
NCT05238623
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI greater than or equal to 18.5 and less than 25 kg / m2, considered adequate or eutrophic (MS, 2011)
* Chest circumference between 44 and 55 cm if fitted to the electrical impedance tomography (EIT) strap size P or M;
* systolic blood pressure lower than 140 mmHg and greater than 100 mmHg
* diastolic blood pressure greater than 60 mmHg and lower than 90 mmHg (VI Brazilian Guidelines for Hypertension, 2010)
* without reports of cardiovascular or pulmonary diseases and symptoms Last month.
Exclusion Criteria
* Presence of cardiac dysfunction assessed by echocardiography;
* Altered pulmonary function by spirometry (PEREIRA et al, 2001) and manovacuometry according to predicted values for healthy individuals (PESSOA et al, 2014).
* Presence of tissue injury in the thorax;
* Dysautonomia that may indicate dysfunction of the autonomic nervous system (ANS), with following clinical manifestations: seizures; epilepsy; Anhydrosis and hyperhidrosis; Neurogenic bladder (CASTRO et al, 1992); (Stewart et al., 2004 and 2005)
* individuals who donated blood or had significant blood loss within 30 days prior to the start of the study (Navarro et al, 1997).
18 Years
35 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade Federal de Pernambuco
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cláudia Thais Pereira Pinto
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cláudia Thais Pinto, Ms
Role: PRINCIPAL_INVESTIGATOR
UFPE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidade Federal de Pernambuco
Recife, PE - Pernambuco, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23031990
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.